2 completed, 2 unknown, 1 active not recruiting. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Unknown 2, Active not recruiting 1 |
Follow Sunburn: new trials by email Literature Review of Sunburn trials Research Report on Sunburn
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Undergraduate Skin Cancer Prevention Trial Education, Action Plan, UV Photo - Skin Cancer | Phase 3 | Active not recruiting | University of Utah | 528 | 2023-04-24 | 2026-07-27 |
| Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn Diclofenac sodium 1mg/g - Sunburn | Phase 3 | Completed | Novartis | 45 | 2006-11-01 | 2007-02-28 |
| Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream Helioblock® SX Cream - Sunburn | Phase 3 | Completed | Loreal USA | 2006-05-01 | 2009-02-11 | |
| Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms Dexchlorpheniramine 1% gel, Dexchlorpheniramine 1% cream - Sunburn | Phase 3 | Unknown | Mantecorp Industria Quimica e Farmaceutica Ltd. | 124 | 2010-11-10 | |
| Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms Dexchlorpheniramine 1% lotion, Dexchlorpheniramine 1% cream - Sunburn | Phase 3 | Unknown | Mantecorp Industria Quimica e Farmaceutica Ltd. | 30 | 2010-03-12 |
Skin Neoplasms (1)
Burns (5) · Photosensitivity Disorders (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Wounds and Injuries (5) · Neoplasms (1) · Neoplasms by Site (1)
dexchlorpheniramine (2) · Diclofenac (1) · Educational Status (1) · Gels (1)
Mantecorp Industria Quimica e Farmaceutica Ltd. (2) · Loreal USA (1) · Novartis (1) · University of Utah (1)
Brazil (2) · United States (2) · France (1)
Catherine Queille- Roussel, MD (1) · Jennifer Hay, PhD (1) · Yelena Wu, PhD (1)